Nutritional Aspects of Noonan Syndrome and Noonan-Related Disorders

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Citação
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, v.170, n.6, p.1525-1531, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Rasopathies are a group of rare disorders characterized by neurocardiofaciocutaneous involvement, and caused by mutations in several genes of the RAS/MAPK pathway. In the present study, we characterized growth parameters, body composition, and nutritional aspects of children and adults (n = 62) affected by these disorders, mainly Noonan syndrome, using an indirect method-anthropometry-and a 24-hr recall questionnaire. The growth parameters in our cohort showed short stature, especially in individuals with RAF1 and SHOC2 mutations, lower obesity rates compared to the control population, and BMI scores highest in individuals with BRAF mutations and lowest in individuals with SHOC2. Body composition showed a compromise in the upper arm muscle circumference, with a statistically significant difference in the z-score of triceps skin-fold (P = 0.0204) and upper arm fat area (P = 0.0388) between BRAF and SHOC2 groups and in the z-score of triceps skinfold between RAF1 and SHOC2 (P = 0.0218). The pattern of macro-nutrient consumption was similar to the control population. Our study is the first to address body composition in RASopathy individuals and the data indicate a compromise not only in adipose tissue, but also in muscle mass. Studies using different techniques, such as dual-energy X-ray absorptiometry or imaging studies, which give a more precise delineation of fat and non-fat mass, are required to confirm our results, ultimately causing an impact on management strategies. (C) 2016 Wiley Periodicals, Inc.
Palavras-chave
growth, body composition, anthropometry, food intake, Noonan syndrome, Noonan related disorders, RAS-MAPK pathway
Referências
  1. Aoki Y, 2015, J HUM GENET, P1
  2. Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084
  3. Bertola DR, 2014, AM J MED GENET A, V164, P2952, DOI 10.1002/ajmg.a.36722
  4. Binder G, 2012, J PEDIATR-US, V161, P501, DOI 10.1016/j.jpeds.2012.02.043
  5. Chen PC, 2010, J CLIN INVEST, V120, P4353, DOI 10.1172/JCI43910
  6. Digilio MC, 2008, EUR J PEDIATR, V167, P621, DOI 10.1007/s00431-007-0558-0
  7. Duren Dana L, 2008, J Diabetes Sci Technol, V2, P1139
  8. Frisancho A. R., 1990, ANTHROPOMETRIC STAND
  9. Gripp KW, 2012, GENET MED, V14, P285, DOI [10.1038/gim.0b013e31822dd91f, 10.1038/GIM.0b013e31822dd91f]
  10. [IBGE] Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ BRAS ORC FAM 20, P130
  11. Institute of Medicine (IOM), 2005, DIET REF INT EN CARB, P1331
  12. Malaquias AC, 2012, AM J MED GENET A, V158A, P2700, DOI 10.1002/ajmg.a.35519
  13. Motil KJ, 2008, PEDIATR RES, V64, P435, DOI 10.1203/PDR.0b013e318180ebcd
  14. Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073
  15. Pierpont MEM, 2014, PEDIATRICS, V134, pE1149, DOI 10.1542/peds.2013-3189
  16. Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523
  17. Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078
  18. Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796
  19. Romano AA, 2010, PEDIATRICS, V126, P746, DOI 10.1542/peds.2009-3207
  20. Shah N, 1999, ARCH DIS CHILD, V81, P28
  21. SHARLAND M, 1992, ARCH DIS CHILD, V67, P178
  22. Shaw AC, 2007, ARCH DIS CHILD, V92, P128, DOI 10.1136/adc.2006.104547
  23. Stevenson D. A., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P145
  24. Tajan M, 2014, P NATL ACAD SCI USA, V111, pE4494, DOI 10.1073/pnas.1406107111
  25. Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002
  26. [FAO] Food and Agriculture Organization of the United Nations, FAOSTAT FOOD BAL
  27. Wells JCK, 2006, ARCH DIS CHILD, V91, P612
  28. WHO] World Health Organization, 2003, DIET NUTR PREV CHRON, P149
  29. WHO] World Health Organization, 2010, WHO ANTHR PC VERS 3
  30. WHO] World Health Organization, 2009, WHO ANTHROPLUS PC IN